目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown

Chapter- 2: Summary and Highlights
Market Outlook
This Report Highlights

Chapter- 3: Market Overview and Definitions
Overview

Chapter- 4: Market Dynamics
Market Drivers
Market Opportunity
Market Restraints

Chapter- 5: Impact of COVID-19
Introduction

Chapter- 6: Market Breakdown by Region
Market Overview and Discussion
Rest of the World

Chapter- 7: Market Breakdown by Treatment Type
Market Overview and Discussion

Chapter- 8: Market Breakdown by Route of Administration
Market Overview and Discussion

Chapter- 9: Market Breakdown by Product
FLT3 Inhibitors
Table 21 : Global Market for AML Treatments, by Product, Through 2028
Figure 8 : Global Market Shares of AML Treatments, by Product, Through 2028

Chapter- 10: ESG Development
Introduction

Chapter- 11: Emerging Trends and Technologies
Introduction

Chapter- 12: Competitive Landscape
Overview
Industry Scenario
Company Shares

Chapter- 13: Patent Analysis
Patent Analysis by Manufacturer

Chapter- 14: Pipeline Analysis
Clinical Trail Scenario

Chapter- 15: M&A and Venture Funding Outlook
Introduction

Chapter- 16: Company Profiles
ABBVIE
AMGEN INC.
ASTELLAS PHARMA INC.
BAYER AG
BIOGEN
BRISTOL MYERS SQUIBB
DAIICHI SANKYO CO. LTD.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
MERCK & CO. INC.
NOVARTIS
PFIZER INC.
SANOFI
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter- 17: Appendix: Acronyms
Table 98 : Acronyms Used in This Report